CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported first-quarter profit of $36.1 million.
The Cambridge, Massachusetts-based company said it had net income of 37 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, came to 73 cents per share.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.
The biopharmaceutical company posted revenue of $413.5 million in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $372.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
